These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10792473)

  • 1. Management of factor XI inhibitor for cardiac intervention: successful treatment with immunosuppressive therapy and plasma exchange.
    Teruya J; Styler M
    Haemophilia; 2000 May; 6(3):158-61. PubMed ID: 10792473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency.
    Ogawa Y; Yanagisawa K; Uchiyama Y; Akashi N; Mieda T; Iizuka H; Inoue M; Shizuka R; Murakami M; Matsumoto N; Handa H
    Int J Hematol; 2018 Oct; 108(4):443-446. PubMed ID: 29713955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged activated partial thromboplastin time (aPTT): not always indicative of increased risk of bleeding].
    van der Pas AJ; Leebeek FW; Perry DJ; Castel A; van Esser JW
    Ned Tijdschr Geneeskd; 2009; 153():B42. PubMed ID: 19785809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI kinetics after plasma exchange in severe factor XI deficiency.
    Nováková IR; van Ginneken CA; Verbruggen HW; Haanen C
    Haemostasis; 1986; 16(1):51-6. PubMed ID: 3699586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired antibody to factor XI in a patient with congenital factor XI deficiency.
    Stern DM; Nossel HL; Owen J
    J Clin Invest; 1982 Jun; 69(6):1270-6. PubMed ID: 6979552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factor XI deficiency, a new way of substitution: human purified concentrates].
    Blanchard N; Jeanjean P; Lepointe F; Dieval J; Ossart M
    Ann Fr Anesth Reanim; 1996; 15(8):1207-10. PubMed ID: 9636796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between factor XI coagulant and factor XI antigenic activity in cattle.
    Gentry PA
    Can J Comp Med; 1984 Jan; 48(1):58-62. PubMed ID: 6713258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated partial thromboplastin time-protamine dose relation in the presence and absence of heparin.
    Inagaki M; Goto K; Katayama H; Benson KT; Goto H; Arakawa K
    J Cardiothorac Anesth; 1989 Dec; 3(6):734-6. PubMed ID: 2521031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report.
    Burgos Pratx LD; Santoro DM; Mileo FG; Martinuzzo ME; Ardiles V; de Santibañes E; Salamone HJ
    Transfus Apher Sci; 2021 Oct; 60(5):103176. PubMed ID: 34127376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazic Jews and the value of activated partial thromboplastin time in its detection.
    Seligsohn U; Modan M
    Isr J Med Sci; 1981 Jun; 17(6):413-5. PubMed ID: 7263201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XI deficiency and aortic valve replacement: Perioperative management.
    Petroulaki A; Lazopoulos G; Chaniotaki F; Kampitakis E; Pavlopoulos D; Chalkiadakis G
    Asian Cardiovasc Thorac Ann; 2017 Jul; 25(6):450-452. PubMed ID: 27091826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency.
    Alsammak MS; Ashrani AA; Winters JL; Pruthi RK
    J Clin Apher; 2017 Dec; 32(6):429-436. PubMed ID: 28295573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative management of factor XI deficiency with therapeutic plasma exchange: A case report and literature review.
    Pagano MB; Konkle BA; Wu Y; Josephson N
    J Clin Apher; 2016 Dec; 31(6):579-583. PubMed ID: 26683249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XI deficiency: detection and management during urological surgery.
    Sidi A; Seligsohn U; Jonas P; Many M
    J Urol; 1978 Apr; 119(4):528-30. PubMed ID: 650760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention in a patient with congenital factor XI deficiency and acquired inhibitor.
    Mungee S; Lapin R; Cavusoglu E; Clark LT; Marmur JD
    Cardiology; 2007; 107(1):69-72. PubMed ID: 16791004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency.
    Salomon O; Zivelin A; Livnat T; Dardik R; Loewenthal R; Avishai O; Steinberg DM; Rosove MH; O'Connell N; Lee CA; Seligsohn U
    Blood; 2003 Jun; 101(12):4783-8. PubMed ID: 12586617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and accurate microplate assay for the determination of factor XI in plasma.
    Scott CF; Colman RW
    J Lab Clin Med; 1988 Jun; 111(6):708-14. PubMed ID: 3373114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of factor XI deficiency.
    Bolton-Maggs PH
    Haemophilia; 1998 Jul; 4(4):683-8. PubMed ID: 9873814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XI deficiency--resolving the enigma?
    Bolton-Maggs PH
    Hematology Am Soc Hematol Educ Program; 2009; ():97-105. PubMed ID: 20008187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of protamine chloride and sulphate in relation to the heparin rebound phenomenon.
    Benayahu D; Aronson M
    Thromb Res; 1983 Oct; 32(2):109-14. PubMed ID: 6658709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.